デフォルト表紙
市場調査レポート
商品コード
1671833

エクソソーム市場:製品・サービス別、適応症別、用途別、製造サービス別、最終用途別、地域別

Exosomes Market, By Product & Service, By Indication, By Application, By Manufacturing Service, By End User, By Geography


出版日
ページ情報
英文 120 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
エクソソーム市場:製品・サービス別、適応症別、用途別、製造サービス別、最終用途別、地域別
出版日: 2025年01月23日
発行: Coherent Market Insights
ページ情報: 英文 120 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のエクソソーム市場は、2025年には2億2,210万米ドルと推定され、2032年には12億8,410万米ドルに達すると予測され、2025年から2032年にかけて28.5%の複合年間成長率(CAGR)を示すと予測されています。

レポート範囲 レポート詳細
基準年 2024年 2025年の市場規模 2億2,210万米ドル
実績データ 2020年から2024年まで 予測期間 2025年から2032年
予測期間:2025年~2032年 CAGR: 28.50% 2032年の価値予測 12億8,410万米ドル
図.エクソソーム市場シェア(%)、地域別、2025年
Exosomes Market-IMG1

エクソソームはナノサイズの細胞外小胞で、タンパク質、脂質、遺伝物質を細胞間に伝達する細胞間メッセンジャーとして機能します。エクソソームは多くの種類の細胞から自然に放出され、宿主細胞を反映する特定の生体分子を運びます。この能力により、エクソソームは腫瘍学、神経学、循環器学など様々な応用分野で潜在的な診断・治療ツールとして浮上しています。複雑な疾患に対するエクソソームに基づく治療と診断の採用が増加しており、予測期間中の市場成長の原動力になると予想されます。

市場力学:

世界のエクソソーム市場の成長は、エクソソーム科学における研究資金の増加、疾患管理におけるエクソソームの臨床応用の増加、エクソソームの利点を活用することに対する製薬会社の関心の高まりなどの要因によって牽引されています。しかし、エクソソームの分離および特性解析技術における技術的課題や、エクソソームを用いた処置に関連する高コストなどの要因が、市場の成長を抑制する可能性が高いです。また、エクソソームに基づく新規療法の発見やドラッグデリバリーへのエクソソームの利用など、現在の課題の克服に役立つ分野での機会も市場に存在します。さらに、ワクチン開発におけるエクソソーム応用への関心の高まりは、予測期間中に新たな道を開くでしょう。

本調査の主な特徴

本レポートでは、世界のエクソソーム市場を詳細に分析し、2024年を基準年とした予測期間(2025-2032年)の市場規模および複合年間成長率(CAGR%)を掲載しています。

また、さまざまなセグメントにわたる潜在的な収益機会を解明し、この市場の魅力的な投資提案のマトリックスについて説明しています。

また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する主要考察も提供しています。

企業ハイライト、製品ポートフォリオ、主要なハイライト、業績、戦略などのパラメータに基づいて、世界のエクソソーム市場の主要企業をプロファイルしています。

本調査の対象となる主要企業には、Thermo Fisher Scientific, Inc.、Bio-Techne、QIAGEN、Lonza、System Biosciences, LLC、Miltenyi Biotech、NX Pharmagen、Aethlon Medical, Inc.、Creative Medical Technologies Holdings, Inc.、Exopharm、RoosterBio, Inc.、Danaher Corporation、Everzom、Ciloa、Unchained Labsなどがあります。

このレポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。

世界のエクソソーム市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者に対応しています。

利害関係者は、世界のエクソソーム市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 調査の目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場の展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー

第3章 市場力学、規制、動向分析

  • 市場力学
  • 影響分析
  • 主な発展
  • 規制シナリオ
  • 製品の発売/承認
  • PEST分析
  • PORTERの分析
  • 合併と買収のシナリオ
  • 業界動向

第4章 世界のエクソソーム市場、製品・サービス別、2020年-2032年、(100万米ドル)

  • キットと試薬
  • 抗体
  • 分離、精製、定量キット
  • その他のキットと試薬
  • 機器
  • サービス

第5章 世界のエクソソーム市場、適応症別、2020年-2032年、(100万米ドル)

  • がん
  • 神経変性疾患
  • 心血管疾患
  • 感染症
  • その他の病気

第6章 世界のエクソソーム市場、用途別、2020年~2032年、(100万米ドル)

  • バイオマーカー
  • ワクチン開発
  • 組織再生
  • ドラッグデリバリー
  • その他

第7章 世界のエクソソーム市場、製造サービス別、2020年-2032年、(100万米ドル)

  • 幹細胞由来エクソソーム
  • 樹状細胞由来エクソソーム
  • その他

第8章 世界のエクソソーム市場、最終用途別、2020年~2032年、(100万米ドル)

  • 学術調査機関
  • 製薬・バイオテクノロジー企業
  • 病院・臨床検査室
  • その他

第9章 世界のエクソソーム市場、地域別、2020年-2032年、価値(100万米ドル)

  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋
  • 中東
  • アフリカ

第10章 競合情勢

  • Thermo Fisher Scientific, Inc.
  • Bio-Techne
  • QIAGEN
  • Lonza
  • System Biosciences, LLC
  • Miltenyi Biotech
  • NX Pharmagen
  • Aethlon Medical, Inc.
  • Creative Medical Technologies Holdings, Inc.
  • Exopharm
  • RoosterBio, Inc.
  • Danaher Corporation
  • Everzom
  • Ciloa
  • Unchained Labs

第11章 アナリストの推奨事項

  • 運命の輪
  • アナリストの見解
  • 一貫した機会マップ

第12章 参考文献と調査手法

  • 参考文献
  • 調査手法
  • 出版社について
目次
Product Code: CMI7732

The Global Exosomes Market is estimated to be valued at USD 222.1 Mn in 2025 and is expected to reach USD 1,284.1 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 28.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 222.1 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 28.50% 2032 Value Projection: USD 1,284.1 Mn
Figure. Exosomes Market Share (%), By Region, 2025
Exosomes Market - IMG1

Exosomes are nano-sized extracellular vesicles that act as intercellular messengers by transferring proteins, lipids, and genetic materials between cells. They are released naturally by many cell types and carry specific biomolecules reflective of the host cells. Due to this ability, exosomes have emerged as potential diagnostic and therapeutic tools across various application areas such as oncology, neurology, and cardiology. The rising adoption of exosome-based therapies and diagnostics for complex diseases is expected to drive the market growth during the forecast period.

Market Dynamics:

The growth of the global exosomes market is driven by factors such as increasing research funding in exosome science, rising clinical applications of exosomes in disease management, and growing focus of pharmaceutical companies on harnessing exosome benefits. However, factors such as technical challenges in exosome isolation and characterization techniques as well as high costs associated with exosome-based procedures are likely to restrain the market growth. The market also presents opportunities in areas such as discovery of novel exosome-based therapies and use of exosomes for drug delivery that can help in overcoming some of the current challenges. Furthermore, growing interest in exosome applications in vaccine development will open up new avenues during the forecast period.

Key Features of the Study:

This report provides in-depth analysis of the global exosomes market and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global exosomes market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., Bio-Techne, QIAGEN, Lonza, System Biosciences, LLC, Miltenyi Biotech, NX Pharmagen, Aethlon Medical, Inc., Creative Medical Technologies Holdings, Inc., Exopharm, RoosterBio, Inc., Danaher Corporation, Everzom, Ciloa, and Unchained Labs

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global exosomes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global exosomes market

Market Segmentation

  • By Product & Service Insights (Revenue, USD Mn, 2020 - 2032)
    • Kits & Reagents
    • Antibodies
    • Isolation, Purification, Quantitation Kits
    • Other Kits & Reagents
    • Instruments
    • Services
  • By Indication Insights (Revenue, USD Mn, 2020 - 2032)
    • Cancer
    • Neurodegenerative Diseases
    • Cardiovascular Diseases
    • Infectious Diseases
    • Other Diseases
  • By Application Insights (Revenue, USD Mn, 2020 - 2032)
    • Biomarkers
    • Vaccine Development
    • Tissue Regeneration
    • Drug Delivery
    • Other Applications
  • By Manufacturing Service Insights (Revenue, USD Mn, 2020 - 2032)
    • Stem Cell-Derived Exosome Manufacturing Services
    • Dendritic Cell-Derived Exosome
    • Others
  • By End User Insights (Revenue, USD Mn, 2020 - 2032)
    • Academic & Research Institutes
    • Pharmaceutical & Biotechnology Companies
    • Hospitals & Clinical Laboratories
    • Others
  • Regional Insights (Revenue, USD Mn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Thermo Fisher Scientific, Inc.
    • Bio-Techne
    • QIAGEN
    • Lonza
    • System Biosciences, LLC
    • Miltenyi Biotech
    • NX Pharmagen
    • Aethlon Medical, Inc.
    • Creative Medical Technologies Holdings, Inc.
    • Exopharm
    • RoosterBio, Inc.
    • Danaher Corporation
    • Everzom
    • Ciloa
    • Unchained Labs

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Exosomes Market, By Product & Service
    • Global Exosomes Market, By Indication
    • Global Exosomes Market, By Application
    • Global Exosomes Market, By Manufacturing Service
    • Global Exosomes Market, By End User
    • Global Exosomes Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Exosomes Market, By Product & Service, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Kits & Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Antibodies
  • Isolation, Purification, Quantitation Kits
  • Other Kits & Reagents
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Exosomes Market, By Indication, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Neurodegenerative Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Cardiovascular Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Other Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Exosomes Market, By Application, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Biomarkers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Vaccine Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Tissue Regeneration
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Drug Delivery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Other Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Exosomes Market, By Manufacturing Service, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Stem Cell-Derived Exosome Manufacturing Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Dendritic Cell-Derived Exosome
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Exosomes Market, By End User, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Academic & Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Pharmaceutical & Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Hospitals & Clinical Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Exosomes Market, By Region, 2020 - 2032, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Manufacturing Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Manufacturing Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Manufacturing Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Manufacturing Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Manufacturing Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Manufacturing Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • Thermo Fisher Scientific, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bio-Techne
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • QIAGEN
  • Lonza
  • System Biosciences, LLC
  • Miltenyi Biotech
  • NX Pharmagen
  • Aethlon Medical, Inc.
  • Creative Medical Technologies Holdings, Inc.
  • Exopharm
  • RoosterBio, Inc.
  • Danaher Corporation
  • Everzom
  • Ciloa
  • Unchained Labs

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us